0086-21-58386256
شناخت آناتومی دندان ها میتواند درک درستی از فرایند دندانپزشکی و مراقبت و نگهداری صحیح از دندان‌ها به ما بدهد. مورفولوژی و اناتومی دندان و فک و دهان را ببینید.
مورفولوژی اسپرم به اندازه، شکل و ظاهر اسپرم اشاره دارد که در صورت غیر طبیعی بودن میتواند باروری را کاهش داده و بارور کردن تخمک را دشوارتر کند.. اسپرم ممکن است بر اساس اندازه سر، داشتن سر اضافی و نداشتن سر یا دم، بد شکل ...
Eluvia is designed to meet the challenges of the superficial femoral artery (SFA) with outstanding flexibility and precise stent placement. Only the Eluvia drug-eluting stent (DES) offers sustained drug release to match the restenosis process in the SFA, with the lowest drug dose density 1 delivered by the most proven polymer.
When asked why Eluvia would provide better results relative to Zilver PTX, Gray said that Eluvia was purpose-built for SFA interventions, whereas Zilver PTX was not as specifically directed toward the SFA. Also, the devices deliver paclitaxel in different ways: Zilver PTX releases the drug rapidly over the course of about 2 months and Eluvia ...
MARLBOROUGH, Mass., Feb. 22, 2016 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced that the Eluvia™ Drug-Eluting Vascular Stent System has received CE Mark and is commencing commercialization immediately in the European Union and other countries where CE Mark is recognized. The Eluvia Stent System is designed to restore …
The SFA is subject to unique mechanical forces like compression and bending, which cause fatigue fractures in stents. 1 The Eluvia Stent is designed to withstand multiple deformation modes including elongation, extreme bending and axial compression, through a balanced spacing of strut connectors.. Custom materials and processing practices, including high …
Eluvia™ is the first polymer-based, drug-eluting stent designed to treat and restore blood flow in the peripheral arteries above the knee specifically the – superficial femoral artery (SFA) and proximal popliteal artery (PPA)the . The Eluvia Stent System utilises the anti-restenotic drug paclitaxel in conjunction with a polymer.
The FDA approval of the Eluvia stent system in September 2018 was based on findings from the IMPERIAL trial, which exhibited the highest 24-month primary patency reported to date for the treatment of femoropopliteal disease in a U.S. pivotal trial with a drug-coated balloon or drug-eluting stent.[iii] Trial data confirmed a statistically ...
%PDF-1.6 %âãÏÓ 232 0 obj > endobj 258 0 obj >/Encrypt 233 0 R/Filter/FlateDecode/ID[95759742A0B9C843B909B50811A004A7>7D087D33FE2D2A45972ADD90B5A80C73>]/Index[232 ...
Physicians discuss the tuned paclitaxel elution profile of the Eluvia Drug-Eluting Stent …
واژه سنگ کریستال (Rock Crystal) از زبان یونانی "krystallos" گرفته شده و از آنجا که سنگ کریستال کوارتز شفاف و بی رنگ بود یونانی ها که در گذشته از خواص سنگ کریستال کوارتز نیز بهره می بردند تصور می کردند که این بلورها مایعاتی است که ...
عروق کرونر، رگ‌هایی هستند که خون را به قلب می‌رسانند. گرفتگی عروق کرونری قلب (cad) عارضه‌ای است که در آن، عروق کرونر باریک و یا مسدود می‌شوند؛ این عارضه معمولاً به دلیل تجمع پلاک در آن‌ها رخ می‌دهد.
معرفی انواع سنگ کوارتز و خواص آن، خواص درمانی و ماورایی سنگ کوارتز، روش شارژ کوارتز، کوارتز سنگ کدام ماه تولد است؟ ... ، مناسب برای قلب و کاهش فشار خون و تنظیم گردش خون وباز شدن و گرفتگی رگ ها و ...
2.1. Device overview. The Eluvia™ stent comprises a self-expanding nitinol stent platform with a coating composed of a polymer system with an antiproliferative active pharmaceutical agent (Figure 1).The geometry of the base stent is such that it provides sufficient force and flexibility to the scaffold while ensuring that it can withstand the …
The Eluvia stent, which features sustained release of the lowest dose of …
Eluvia DES is designed to meet the challenges of the SFA with outstanding flexibility and precise stent placement. Only Eluvia DES offers sustained drug release, with the world's most proven polymer, to match the …
の（PAD）のステントについて、ポリマー・パクリタキセルステント（Eluvia）は、ポリマー・パクリタキセルステント（Zilver PTX）にし、12ヵの1およびにしてであることがされた。・Lankenau Heart Institute ...
فرآیندهای اصلی استخراج طلا در این نوع خاک طلا به طور خلاصه عبارتند از: جداسازی گرانشی یا تغلیظ گرانشی، افزودن جیوه و حذف ناخالصی ها، جدا سازی طلا از جیوه و نهایتا ذوب طلا می باشد.. 2- سنگ طلای پلاسری معادن قدیمی
The Eluvia™ Drug-Eluting Vascular Stent System is available under CE Mark only and is not approved in the United States. Peripheral artery disease (PAD) is estimated to affect approximately 12% to 14% of the general population today, and this percentage only increases with age (about 20% of adults older than 75 years are believed to be …
Purpose: This multicenter, prospective, observational study aimed to compare Zilver PTX and Eluvia stents in real-world settings for treating femoropopliteal lesions as the differences in the 1-year outcomes of these stents have not been elucidated. Materials and methods: Overall, 200 limbs with native femoropopliteal artery disease were treated with …
EMINENT Trial: A global randomized controlled multi-center trial with 2:1 randomization of the Eluvia™ Drug-Eluting Stent against commercially-available Self-Expanding Bare Nitinol Stents, single-blind, superiority design; independent core lab adjudication. Primary Endpoint: 1-Year Binary Primary Patency rate of 83.2% in the Eluvia arm vs. 74 ...
Only Eluvia DES offers sustained drug release, with the world's most proven polymer, to …
مقدمه‌ای بر مورفولوژی سلول‌های خون محیطی. برای بررسی سلول‌های خونی و شناسایی ناهنجاری‌های سلولی در بیماری‌های خونی لازم است که یک هماتولوژیست توانایی شناسایی سلول‌های نرمال و آشنایی با سلول های مختلف خونی در ...
Un tratamiento innovador para su uso en la FSA que mejora considerablemente la permeabilidad en comparación con los stents metálicos y farmacoactivos. El sistema de stent de SFA farmacoactivo Eluvia demostró una permeabilidad primaria de 12 meses de un 96,1 %, la más alta conocida hasta la fecha.
پزشک در ابتدا جریان خون رگ را متوقف می‌کند و سپس پلاک‌های موجود در رگ و یا قسمت آسیب‌دیده از رگ را جدا می‌کند و سپس دو قسمت رگ را به هم متصل می‌کند تا جریان خون به مغز بهبود پیدا کند.
The Eluvia drug-eluting vascular stent system (Boston Scientific, MA, USA) was designed with a biocompatible fluoropolymer coating to allow for drug elution over time. Initial clinical results demonstrate promising efficacy in terms of sustained femoropopliteal artery patency along with a good safety profile. This review summarizes the existing ...
The Eluvia drug-eluting vascular stent system (Boston Scientific, MA, …
MARLBOROUGH, Mass., Sept. 28, 2015 /PRNewswire/ -- New 12-month clinical trial outcomes assessing the safety and performance of the Boston Scientific (NYSE: BSX) Eluvia™ Drug-Eluting Vascular Stent System reflect a primary patency rate 1 of more than 96 percent. These results represent the highest 12-month primary patency reported for …
The Eluvia™ stent was designed to perform in the unique environment of the SFA. Its polymeric coating allows for pacli-taxel elution over a long period of time to overlap the timeline associated with peripheral arterial restenosis. The available preclinical and clinical data on treatment with Eluvia™suggest
In this study, use of the Eluvia polymer-based DES for the treatment of …
The FDA's approval is based on findings from the IMPERIAL trial, in which the Eluvia stent demonstrated superior results in the first superficial femoral artery head-to-head drug-eluting stent trial. 2 In this trial, patients treated with the Eluvia stent experienced a significantly greater 12-month primary patency of 92.1 percent, compared to ...
In addition to showing a superior result in terms of primary patency, IMPERIAL established that Eluvia was noninferior to Zilver PTX in terms of major adverse events, with numerically—but nonsignificantly—lower rates of TLR and stent thrombosis in the Eluvia arm.